Discovery Bioanalysis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Status : Ongoing | Report Code : FACT4724MR

Discovery Bioanalysis Market: Introduction

Discovery bioanalysis is a rapid non-GLP (good laboratory practice) technique which provides bioanalytical data by minimizing the time and cost during the early and late stages of drug discovery. The demand for discovery bio-analysis market is increasing rapidly particularly in the biotechnology and pharmaceutical industry. The biotechnology and pharmaceutical companies are highly dependent on contract research organization in conducting bioanalytical services, because of the difficulties of high cost and time which are expected to fuel the growth of the discovery bio-analysis market during forecasting periods. Besides, the growing prevalence of chronic and infectious diseases is also expected to boost the growth of discovery bio-analysis market. Increased investments in research and drug development across the world by biopharmaceutical companies also propelling the growth of discovery bioanalysis market. Furthermore, the booming growth of the medical cosmetic industry in recent years with the high investment towards medical research and development expected to accelerate the discovery of bioanalysis market growth. Also, the market entrance of a large number of companies and manufacturers providing discovery bio-analysis services for drug development is expected to propel the growth of discovery bioanalysis market. Growing demand for customized and personalized drug is expected to booming the growth of discovery bioanalysis market. Increasing health expenditures of the peoples across the world is also another factor expected to drive the growth of discovery bioanalysis market. However, factors such as expensive treatment and strict regulatory policies slowing the growth of discovery bioanalysis market.

Discovery Bio-analysis Market: Drivers and Restraints

The rise in the incidence of chronic diseases across the world is one of the major factor expected to propel the growth of discovery bioanalysis market. Also, the cost-effectiveness of bioanalytical testing services outsourcing as compared to in-house analysis is one of the factors expected to boost the market growth during forecast periods. Increasing demand for bioanalytical services by pharmaceutical and biotechnological companies drives the growth of discovery bioanalysis market. The rapid growth of the cosmetic treatment industry and the increasing expenditure towards innovative drug development expected to accelerate the growth of discovery bioanalysis market. Moreover. However, the strict regulatory policies and a high initial setup cost expected to hamper the growth of discovery bioanalysis market.

Discovery Bio-analysis Market: Segmentation

The discovery bioanalysis market can be segmented as test type, molecule type, service type and end-user

Based on the test type discovery bioanalysis market is segmented as:

  • ADME (absorption, distribution, metabolism, and excretion)
  • Pharmacodynamics
  • Pharmacokinetic
  • Bioequivalence
  • Bioavailability
  • Others

Based on the molecule type discovery bioanalysis market is segmented as:

  • Small Molecules
  • Large Molecules
  • Vaccines

Based on the service type discovery bioanalysis market is segmented as:

  • Nonclinical Bioanalysis Services
  • Clinical Bioanalysis Services

Based on the end-user discovery bioanalysis market is segmented as:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Others

Discovery Bio-analysis Market: Overview

The market of discovery bioanalysis is rapidly increasing due to its growing application for the analysis of biotechnological and pharmaceutical products. Biopharmaceutical companies are increasingly looking for contract research development companies for discovery bioanalysis services due to low cost and time as compared to in house analysis. Moreover, the increasing demand for discovery bioanalysis services for generic drug development by the key pharmaceutical market players is also expected to boost the demand for discovery bioanalysis market over forecast periods.

Discovery Bio-analysis Market: Regional Outlook

The U.S. is expected as the leading market of discovery bioanalysis due to growing demand for bioanalytical services; increasing research and development expenditure. In addition, presence of highly reliable and high-end pharmaceutical companies and increasing clinical trials are the major factors contributing for the discovery bioanalysis market growth in this region followed by Europe However, the highly populated Asian countries such as India and China with increasing incidences of chronic diseases and growing biopharmaceutical industry expected to increase the discovery bioanalysis market with huge growth opportunities for the market players in these regions.

Discovery Bio-analysis Market: Key Players

Examples of some of the key players operating discovery bio-analysis market are Covance, Inc., ICON Plc,., Charles River Laboratories International, Inc., Eurofins Scientific, Bio-Rad Laboratories, Inc., and WuXi AppTec among others

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
  • Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
  • The Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)

Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Discovery bioanalysis is a rapid non-GLP (good laboratory practice) technique which provides bioanalytical data by minimizing the time and cost during the early and late stages of drug discovery. The demand for discovery bio-analysis market is increasing rapidly particularly in the biotechnology and pharmaceutical industry. The biotechnology and pharmaceutical companies are highly dependent on contract research organization in conducting bioanalytical services.

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Discovery Bioanalysis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029